In December 2019, an outbreak of COVID-19, caused by the novel coronavirus known as SARS-CoV-2, was detected in mainland China. Since then, researchers have been
tracking the spread of the virus. At NIH,
scientists mobilized to respond to the need for accurate coronavirus testing, development of effective treatments and vaccines, and
establishment of treatment guidelines.
The National Institute of Allergy and Infectious Diseases (NIAID) leads
NIH COVID-19 clinical research, and NIH research to
develop therapeutics and vaccines for coronaviruses. So far, the
FDA has authorized two vaccines for emergency use.
Fogarty grantees, trainees and fellows across geographic areas and research disciplines are helping to lead and support
COVID-19 response efforts and research activities in some low-resource countries and regions.
Minor revisions February 25, 2021 | Major revisions July 15, 2020